A citation-based method for searching scientific literature

Janis M Taube, Robert A Anders, Geoffrey D Young, Haiying Xu, Rajni Sharma, Tracee L McMiller, Shuming Chen, Alison P Klein, Drew M Pardoll, Suzanne L Topalian, Lieping Chen. Sci Transl Med 2012
Times Cited: 1566



Enfu Hui, Jeanne Cheung, Jing Zhu, Xiaolei Su, Marcus J Taylor, Heidi A Wallweber, Dibyendu K Sasmal, Jun Huang, Jeong M Kim, Ira Mellman, Ronald D Vale. Science 2017
Times Cited: 779




List of shared articles



Times cited

The foundations of immune checkpoint blockade and the ipilimumab approval decennial.
Alan J Korman, Sarah C Garrett-Thomson, Nils Lonberg. Nat Rev Drug Discov 2022
16

Programmed death ligand 1 signals in cancer cells.
Anand V R Kornepati, Ratna K Vadlamudi, Tyler J Curiel. Nat Rev Cancer 2022
13

Research progress of tumor targeted drug delivery based on PD-1/PD-L1.
Dongzhu Liu, Shan Gao, Yujia Zhai, Xiaoye Yang, Guangxi Zhai. Int J Pharm 2022
4

ATRA promotes PD-L1 expression to control gastric cancer immune surveillance.
Zhi-Lu Ma, Yan-Li Ding, Jing Jing, Lin-Na Du, Xu-Yang Zhang, Hong-Min Liu, Peng-Xing He. Eur J Pharmacol 2022
0

Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer.
Yu-Meng Wang, Jun-Jun Qiu, Xin-Yu Qu, Jing Peng, Chong Lu, Meng Zhang, Ming-Xing Zhang, Xing-Ling Qi, Bin Lv, Jing-Jing Guo,[...]. Oncoimmunology 2022
4

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis.
Tynisha S Rafael, Jossie Rotman, Oscar R Brouwer, Henk G van der Poel, Constantijne H Mom, Gemma G Kenter, Tanja D de Gruijl, Ekaterina S Jordanova. J Clin Med 2022
1